American Society of Hematology

SHERPA: Blue

People

  1. Intlekofer
    Intlekofer
  2. Seshan
    Seshan
  3. Younes
    Younes
  4. Zelenetz
    Zelenetz
  5. Moskowitz
    Moskowitz
  6. Palomba
    Palomba
  7. Batlevi
    Batlevi
  8. Copeland
    Copeland
  9. Dogan
    Dogan
  10. Pichardo
    Pichardo

Groups

  1. Biostatistics Service (6)
  2. Center for Hematologic Malignancies (6)
  3. Center for Pancreatic Cancer Research (6)
  4. Department of Medicine (6)
  5. Epidemiology and Biostatistics (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)
  7. GSK Faculty (6)
  8. Hematologic Malignancies Research (6)
  9. Hematologic Malignancies, Division of (6)
  10. Human Oncology and Pathogenesis Program (6)
Search Within
  1. "Center for Pancreatic Cancer Research"
  2. "Amanda Copeland"
Formats
  1. Meeting Abstract (6)
Groups
  1. Biostatistics Service (6)
  2. Center for Hematologic Malignancies (6)
  3. Center for Pancreatic Cancer Research (6)
  4. Department of Medicine (6)
  5. Epidemiology and Biostatistics (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Amanda Copeland (6)
  2. Anas Younes (6)
  3. Andrew Intlekofer (6)
  4. Andrew Zelenetz (6)
  5. Venkatraman Seshan (6)
  6. Craig Moskowitz (5)

More People

Years
  1. 2016 (2)
  2. 2015 (2)
  3. 2014 (1)
  4. 2013 (1)
Publications
  1. Blood (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Distinctive genomic alterations in testicular diffuse large B cell lymphoma
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Wang, L.; Intlekofer, A. M.; Copeland, A. R.; Jungbluth, A. A.; Reiner, A.; Pichardo, J. D.; Gallagher, M.; Bouvier, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save